Pharma Responds To Sandy’s Wrath With Delays
This article was originally published in The Pink Sheet Daily
Executive Summary
As the East Coast braces for the impact of Hurricane Sandy, companies choose the safety of their employees over keeping financial releases on schedule.
You may also be interested in...
FDA Faced With A Judgment Call On Hydrocodone Upscheduling
Commenters in favor of and opposed to new restrictions on combination hydrocodone products make strong cases, but without much new data.
Pharma Only Slightly Winded By Hurricane Sandy
While most of the East Coast of the U.S. continues to struggle with the aftereffects of Hurricane Sandy, pharmaceutical industry operations are back to normal and the companies are doing what they can to help out.
AbbVie Issues Record Debt To Support Independence
The future Abbott spin-off tapped the bond market for financing just days after Hurricane Sandy brought trading to a halt and hours before the U.S. faced a leadership decision.